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ASXL gain-of-function truncation mutants:
defective and dysregulated forms of a
natural ribosomal frameshifting product?
Adam M. Dinan1, John F. Atkins2,3 and Andrew E. Firth1*
Abstract
Background: Programmed ribosomal frameshifting (PRF) is a gene expression mechanism which enables the
translation of two N-terminally coincident, C-terminally distinct protein products from a single mRNA. Many viruses
utilize PRF to control or regulate gene expression, but very few phylogenetically conserved examples are known in
vertebrate genes. Additional sex combs-like (ASXL) genes 1 and 2 encode important epigenetic and transcriptional
regulatory proteins that control the expression of homeotic genes during key developmental stages. Here we
describe an ~150-codon overlapping ORF (termed TF) in ASXL1 and ASXL2 that, with few exceptions, is conserved
throughout vertebrates.
Results: Conservation of the TF ORF, strong suppression of synonymous site variation in the overlap region, and
the completely conserved presence of an EH[N/S]Y motif (a known binding site for Host Cell Factor-1, HCF-1, an
epigenetic regulatory factor), all indicate that TF is a protein-coding sequence. A highly conserved UCC_UUU_CGU
sequence (identical to the known site of +1 ribosomal frameshifting for influenza virus PA-X expression) occurs at the
5′ end of the region of enhanced synonymous site conservation in ASXL1. Similarly, a highly conserved RG_GUC_UCU
sequence (identical to a known site of −2 ribosomal frameshifting for arterivirus nsp2TF expression) occurs at the
5′ end of the region of enhanced synonymous site conservation in ASXL2.
Conclusions: Due to a lack of appropriate splice forms, or initiation sites, the most plausible mechanism for translation
of the ASXL1 and 2 TF regions is ribosomal frameshifting, resulting in a transframe fusion of the N-terminal half of
ASXL1 or 2 to the TF product, termed ASXL-TF. Truncation or frameshift mutants of ASXL are linked to myeloid
malignancies and genetic diseases, such as Bohring-Opitz syndrome, likely at least in part as a result of gain-of-function
or dominant-negative effects. Our hypothesis now indicates that these disease-associated mutant forms represent
overexpressed defective versions of ASXL-TF.
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Background
The shifting of ribosomes between reading frames whilst
decoding mRNA transcripts can give rise to protein iso-
forms with distinct C-terminal sequences, and often
quite different lengths, from the equivalent products of
standard decoding [1]. Specific features of the mRNA se-
quence can evolve to increase or modulate the frequency
with which frameshifting occurs and, in such cases, the
process may be referred to as programmed ribosomal
frameshifting (PRF) [2]. PRF is commonly utilized in
virus gene expression, where it serves to control the ra-
tio of different enzymatic or structural proteins, or to
allow access to overlapping open reading frames (ORFs)
thus increasing the coding capacity of small virus ge-
nomes [3].
In viruses, the most common type of PRF involves −1
tandem slippage of the P- and A-site tRNAs on a “slip-
pery” heptanucleotide sequence with consensus motif
X_XXY_YYZ (where XXX represents any three identical
nucleotides, although certain exceptions occur – such as
GGU and GUU; YYY represents AAA or UUU; Z repre-
sents A, C, or U; and underscores seperate zero-frame
codons). Such sequences allow for substantial codon:an-
ticodon re-pairing following a −1 PRF. For efficient −1
PRF, however, an extra stimulatory element is required
and this normally takes the form of a downstream RNA
stem-loop or pseudoknot structure separated from the
heptanucleotide shift site by a 5–9 nt “spacer” region.
Such RNA-structure-stimulated frameshifting normally
results in a fixed ratio of frameshift to non-frameshift
protein products. In two cases, PRF is known to be
stimulated by virus proteins binding to the mRNA
downstream of the shift site and, in such cases, the fra-
meshifting efficiency can be modulated as levels of virus
protein increase over the course of infection [4, 5].
Ribosomes can access the other available reading
frame via either +1 or −2 PRF. The cis-acting sequences
directing “plus direction” frameshifting events have
generally been less well-defined than those associated
with −1 PRF [6]. However, a number of specific in-
stances have been documented. For example, ~1–2%
efficient +1 PRF occurs at a highly-conserved UCC_
UUU_CGU sequence during translation of the influenza A
virus PA gene, giving rise to the transframe protein PA-X
[6, 7]. The precise mechanistic basis for +1 PRF in this case
remains unclear; however, it has been proposed to involve
P-site slippage of the single isoacceptor phenylalanine tRNA
(anticodon 3′-AAG-5′) on the UUU_C tetranucleotide.
The identities of the A-site (CGU) and E-site (UCC) codons
also affect the PRF efficiency, but there appears to be no
strong dependence on more distal sequence elements [7].
Similar sequences are conserved and have been proposed as
the sites of +1 frameshifting in chronic bee paralysis and re-
lated viruses, amalgaviruses, and fijiviruses [6, 8].
In arteriviruses, ~20%-efficient −2 PRF occurs at a
slippery sequence in the nsp2-encoding region of the
pp1a gene [4, 9, 10]. In this case, the shift site is nor-
mally RG_GUU_UUU or RG_GUC_UCU (R = purine),
depending on virus species, allowing codon:anticodon
re-pairing in the A-site following a −2 shift. Unlike ca-
nonical “minus direction” frameshifting, −2 PRF in arter-
iviruses does not appear to require the presence of a
downstream stimulatory RNA secondary structure, but
instead involves the binding of a protein complex –
comprising the viral nsp1β protein and cellular Poly(C)-
Binding Proteins (PCBPs) – to a downstream C-rich
sequence separated from the shift site by a “spacer” re-
gion of 10 nt [4].
There are very few known cases of biologically
relevant PRF in vertebrate cellular genes. The gene for
antizyme – a negative regulator of cellular polyamine
levels – utilizes +1 PRF to regulate synthesis of antizyme
as part of a feedback loop where the efficiency of frame-
shifting increases in response to elevated polyamine
levels [11, 12]. As in many retrotransposons, the
retrotransposon-derived genes PEG10, PNMA3, PNMA5
and ZCCHC5 contain canonical −1 PRF sites [13, 14].
To our knowledge, no other conserved (i.e. subject to
purifying selection) cases of PRF are known in vertebrate
nuclear-encoded genes [1]. The limited informational
content of +1 PRF sites makes their computational iden-
tification challenging. However, it is most feasible in
cases where the sequence of the frameshift site is phylo-
genetically conserved; and where ribosomes which shift
frame do not immediately encounter a stop codon, but
rather continue to synthesize a so-called “transframe”
protein product. During a routine scan of vertebrate ge-
nomes, we identified a single highly conserved instance
of the influenza A virus UCC_UUU_CGU +1 shift site.
This is located in a central region of the ASXL1 coding
sequence, and coincides with the conserved presence of
a long +1 frame overlapping ORF (hereafter TF, from
“transframe”) and statistically significantly enhanced syn-
onymous site conservation in the zero-frame. A corre-
sponding +1 frame overlapping ORF is also present in
ASXL2, but here the ORF is associated with a highly
conserved arterivirus RG_GUC_UCU −2 shift site
(Fig. 1).
ASXL genes encode regulatory proteins of the enhan-
cer of trithorax and polycomb (ETP) group, which
modulate the expression of homeotic genes during em-
bryogenesis [15, 16]. There are three paralogous mem-
bers of the ASXL family in vertebrates (ASXL1–3) [17],
and a single homologous gene (ASX) in Drosophila [18].
ASXL proteins function as epigenetic scaffolds, capable
of interacting with chromatin modification complexes,
and can also independently bind to a number of tran-
scription factors [16]. Despite their varying lengths, the
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ASXL genes share a conserved architecture; with each gene
comprising a total of 13 exons and 12 introns (Fig. 1). Exon
13 is by far the longest in each case, accounting for almost
three-quarters of full-length ASXL mRNA transcripts, and
including the entire 3′ untranslated region (UTR) [17, 19].
The locations of the splice junctions at intron-exon bound-
aries have been confirmed experimentally, and their se-
quences are highly conserved [17].
A number of domains are found in ASXL proteins, the
relative locations of which are broadly conserved (Fig. 1).
Encoded at the extreme N terminus of each protein is the
ASXN domain (also known as the HB1, ASXL, restriction
endonuclease helix-turn-helix or HARE-HTH domain),
which is predicted to facilitate interactions with DNA
[20]. Downstream of ASXN is the ASX homology (ASXH)
domain (also known as the DEUBAD domain) encoded by
exons 9–11, which participates in interactions with epi-
genetic regulatory proteins, including the BRCA1 Associ-
ated Protein 1 (BAP1) deubiquitinating protease [21–23].
The predicted PRF sites in ASXL1 and ASXL2 occur
within the regions encoding the non-globular ASXM1
domain and the binding site of the transcriptional co-
regulator SRC-1 (NCOA1) [24, 25]. Frameshifting at the
predicted sites would give rise to truncated forms of the
ASXL proteins, ASXL1-TF and ASXL2-TF, lacking the
C-terminal ASXM2 and plant homeodomain (PHD) do-
mains, which appear to function primarily in binding to
nuclear hormone receptors [25], and to histone proteins
[26], respectively, but acquiring a conserved EH[N/S]Y
motif close to the C-terminus of TF.
Results
A conserved overlapping ORF in a central region of
mammalian ASXL1 and ASXL2
Following the identification of UCC_UUU_CGU as the
site of +1 PRF in influenza A virus [6], we screened
37,257 human mRNA RefSeq CDSs from the National
Center for Biotechnology Information (NCBI) database
for in-frame UCC_UUU_CGU sequences. We found 12
unique matches (i.e. excluding the same match occurring
in different transcript isoforms) of which one – in
ASXL1 – was conserved in mouse, chimpanzee, cow and
chicken. The two paralogous members of the ASXL fam-
ily (ASXL2 and ASXL3) were also inspected. Neither
paralogue was found to contain an influenzavirus-like +1
PRF sequence; however, ASXL2 was found to contain an
arterivirus-like −2 PRF shift site sequence, RG_GU-
C_UCU, at a location similar to that of the ASXL1 +1
PRF sequence, and conserved in the same species. In hu-
man, the ASXL1 and ASXL2 shift site sequences are
followed by +1-frame ORFs of 153 and 161 codons, re-
spectively. Frameshift translation of the overlapping
ORFs would result in transframe fusion proteins of 77
and 89 kDa (ASXL1-TF and ASXL2-TF) compared to
165 and 154 kDa for the full-length zero-frame products
(ASXL1 and ASXL2) (Additional file 1: Figure S1).
Conservation of the frameshift site and overlapping ORF
Following initial identification in a limited number of se-
quences, we next expanded the datasets for both ASXL1
and ASXL2 to include mRNA sequences from each of
the major clades of vertebrates. Specifically, we queried
the NCBI non-redundant nucleotide (nr/nt) and tran-
scriptome shotgun assembly (TSA) databases to detect
orthologues of both genes, resulting in the identification
of sequences from 200 species for ASXL1 and 129 spe-
cies for ASXL2 (Additional file 1).
In the case of ASXL1, the UCC_UUU_CGU sequence
was found to be conserved in each species for which a
sequence was identified, with the sole exception of the
Australian ghostshark (Callorhinchus milii), in which
the last nucleotide is a G rather than a U (i.e.
UCC_UUU_CGG) (Fig. 2a). Studies with reporter con-
structs have shown that the presence of a CGG codon at
this position, rather than CGU, reduces the efficiency
of +1 PRF at the influenza A virus shift site by ~50%
[7]. Hence, these data are consistent with the occurrence
of PRF in the ASXL1 gene of the Australian ghostshark,
Fig. 1 Architecture of human ASXL mRNA transcripts. Each transcript comprises 13 exons, with exon 13 being the longest. The zero-frame coding
regions (1541, 1435 and 2248 codons respectively) for each transcript are shown in light blue. Exon boundaries are denoted by vertical dashed lines;
exon 3 (3 nt) is not visible in the figure. The locations of conserved domains are indicated, according to the colour legend. The conserved +1 and −2
PRF shift sites are shown for ASXL1 (UCC_UUU_CGU) and ASXL2 (G_GUC_UCU). Ribosomes which frameshift would translate a conserved +1 frame
ORF (pink). ASXN: ASX N-terminal domain; ASXH: ASX homology domain; ASXM: ASX middle domain; PHD: plant homeodomain
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although perhaps at a lower efficiency when compared
with other vertebrates. The putative shift site sequence is
followed by a +1-frame ORF with median length of 153,
138, 126 and 163 codons in mammals, sauropsids, am-
phibians and teleost fish, respectively, and 158, 139 and
162 codons in coelacanth (Latimeria chalumnae), spotted
gar (Lepisosteus oculatus) and Australian ghostshark (see
Additional file 1).
In the case of ASXL2 (Fig. 2b), the RG_GUC_UCU se-
quence was found to be conserved in all taxa, apart from
lizards (represented by a single species, Anolis carolinensis)
and teleost fish. The lizard sequence is apparently diver-
gent from those of other reptiles, in which the RG_GU-
C_UCU sequence is fully conserved. A single teleost
ASXL2 sequence – from the early-branching Scleropages
formosus [27] – contains the RG_GUC_UCU sequence,
but the corresponding +1-frame TF ORF is short (20 co-
dons). In contrast, the sequences from spotted gar and
Australian ghostshark contain the RG_GUC_UCU se-
quence and full-length TF ORFs. Hence, a parsimonious
interpretation of these data is that ASXL2 in the last com-
mon ancestor of bony and cartilaginous fish contained the
TF ORF but it was secondarily lost within teleosts. The pu-
tative shift site sequence is followed by a +1-frame ORF
with median length of 161, 156 and 152 codons in
mammals, sauropsids and amphibians, respectively, and
155, 153 and 138 codons in coelacanth, spotted gar and
Australian ghostshark (see Additional file 1).
Within each well-represented vertebrate clade (i.e.
mammals, sauropsids, amphibians and teleost fish),
codon-based alignments of the zero-frame ASXL coding
regions of all identified orthologues were constructed,
and synonymous site conservation was assessed as previ-
ously described [28]. In each alignment highly significant
synonymous site conservation was observed in a region
coincident with the +1 frame TF ORF (Fig. 3 and
Additional file 1: Figure S2; see Table 1 for p-values).
The predicted PRF shift sites occur at the 5′ end of the
region of conservation and notably often correspond to
specific conservation peaks when synonymous site con-
servation was analyzed at higher resolution (Fig. 3 and
Additional file 1: Figure S3). Known dual coding regions
(e.g. in viruses) are frequently characterized by signifi-
cant synonymous site conservation in the overlapping
zero-frame, reflecting constraints on sequence evolution
imposed by the overlapping feature [28]. Although over-
lapping non-coding features (such as functional RNA
structures) may also lead to enhanced synonymous site
conservation, the highly conserved presence of a long
open reading frame in two distinct paralogues, i.e.
ASXL1 and ASXL2, argues in favour of an overlapping
coding sequence.
We considered possible explanations for TF ORF ex-
pression, other than ribosomal frameshifting. In particu-
lar, it is conceivable that a previously unrecognized
alternative splice variant might fuse the TF ORF in-
frame with the canonical ASXL CDS. Several transcript
isoforms have been identified for both ASXL1 and
ASXL2, although the majority of these seem to result
from the use of alternative poly-adenylation signals in
Fig. 2 Codon alignments of selected ASXL sequences in the vicinity of the predicted frameshift sites. a ASXL1. b ASXL2. To avoid over-representation
of closely related sequences, sequence logos are based on alignments of 76 (ASXL1) and 52 (ASXL2) sequences from phylogenetically diverse taxa
(see Additional file 1). Selected individual sequences from major vertebrate clades are shown beneath. Asterisks indicate conservation of residues
within the full alignments, while dashes indicate insertions or deletions within those alignments. Zero-frame codons are separated by spaces and the
predicted frameshift sites are highlighted in yellow
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the 3′ UTR [17, 29]. Alternative splice site usage has
also been documented. For example, the existence of a
second major isoform of ASXL1 has been experimentally
verified in human cells, which results from the
utilization of an alternative fourth exon [30]; however,
this transcript also does not allow in-frame expression of
the TF ORF. To systematically search for annotated al-
ternative splice variants (or completely independent
mRNAs) that might allow translation of the TF peptide,
we queried the NCBI blastp non-redundant protein (nr)
database using the translated TF ORF sequences of
ASXL1 and ASXL2 from human. A small number of
non-human hits were found in both cases, though all
were based upon computational gene predictions and
none covered the query sequence completely. Alignment
of the zero-frame sequences of ASXL1 and ASXL2 with
these database hits suggests that the splice junctions
have been mis-annotated in the latter, apparently due to
missing or incomplete underlying genomic sequence
data. For example, the best match to the ASXL2 TF pep-
tide sequence was a hypothetical protein (A6R68_07077)
Fig. 3 Synonymous site conservation in the ASXL1 and ASXL2 coding regions in tetrapods. a In each subfigure, the top panel shows a schematic
of the zero-frame ORF (pale blue) and the overlapping TF ORF (pink). The next two panels show positions of stop codons (blue) in the +1 and +2
reading frames, and alignment gaps (grey) in each sequence of the sequence alignment. The vertical green line in the +1 frame panel shows the
position of the putative frameshift site. The bottom two panels show the synonymous site conservation analysis, with the magenta line (lower
panel) indicating the ratio of the observed number of substitutions within a given window to the number expected under a null model of neutral
evolution at synonymous sites, and the red line (upper panel) showing the corresponding p-value. The analysis uses a 25-codon sliding window.
The horizontal dashed grey line indicates a p = 0.05 threshold after a correction for multiple testing (namely scaling by [25-codon window size]/
[ASXL CDS length]. b As above, but with a 9-codon sliding window. The vertical green and blue lines show the positions of the putative frameshift
site and the conserved EH[N/S]Y, respectively. (See Additional file 1: Figs. S2 and S3 for teleost fish besides separate mammalian, sauropsid and
amphibian analyses)
Table 1 Zero-frame observed/expected (obs/exp) synonymous
substitution ratios and corresponding p-values for the TF region
Gene Taxon Synonymous site conservation
obs/exp p-value
ASXL1 mammals 0.33 3.3 × 10−82
sauropsids 0.55 4.4 × 10−29
amphibians 0.43 6.3 × 10−19
tetrapods 0.43 4.8 × 10−121
teleosts 0.52 3.2 × 10−49
ASXL2 mammals 0.68 7.6 × 10−22
sauropsids 0.86 5.7 × 10−3
amphibians 0.75 6.0 × 10−4
tetrapods 0.74 1.3 × 10−22
Note that these p-values are for the entire TF ORF and therefore can be lower
than the 25-codon sliding window p-values of Fig. 3 and Additional file 1: Fig. S2
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from Neotoma lepida (GenBank accession OBS64385.1).
However, the genomic sequence upon which the gene
prediction is based (LZPO01097212.1) contains numer-
ous large gaps, which are likely to have affected the pre-
diction of splice junctions, and, in fact, the start codon
of the gene has not been annotated. We conclude that
there is currently no robust evidence for alternative spli-
cing providing a potential mechanism to access the
ASXL1 or ASXL2 TF ORFs.
Independent expression of the ASXL1 and ASXL2 TF
polypeptides is also unlikely given the lack of appropri-
ately positioned AUG codons within the TF ORF
sequences (Additional file 1: Figure S4).
Amino acid composition of the TF peptides
TF peptide sequences were determined by translating
the +1 reading frames from the 3′ ends of the predicted
PRF shift sites to the nearest in-frame stop codons (see
Additional file 1: Figure S1). The TF peptides of phylo-
genetically representative species from each major verte-
brate clade were then aligned, and residue conservation
was assessed [31]. For both ASXL1 (Fig. 4) and ASXL2
(Fig. 5), conservation of amino acids was observed in the
N-terminal region of TF. This relatively high level of
conservation could potentially reflect selective constraints
on the nucleotide sequence due to potential 3′ PRF-
stimulatory elements and/or amino acid coding constraints
in the zero-frame-encoded ASXM1 domain (Fig. 1). None-
theless, it is apparent that amino acids with particular
physicochemical properties are maintained at specific sites.
For example, there are five positions in the alignment of
ASXL1 TF peptides at which a basic (K/R) amino acid is
found in all sequences, four of which are in the N-terminal
region (positions 10, 17, 20, and 38 in Fig. 4).
A four amino acid motif, EH[N/S]Y, was found to be
common to the C-terminal regions of all TF sequences
Fig. 4 Amino acid composition of ASXL1 TF peptide sequences. To avoid over-representation of closely related sequences, the sequence logo is
based on an alignment of 76 sequences from phylogenetically diverse taxa (see Additional file 1: Figure S2). Selected representative sequences
are shown beneath the logo. Partial-width logo letters correspond to positions with alignment gaps (i.e. fewer contributing sequences)
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analysed, both for ASXL1 and ASXL2 (Figs. 4 and 5).
This motif is commonly followed by a serine (S) or a
hydrophobic residue, and – in the case of ASXL2 only –
by a proline (P) residue typically located four amino
acids downstream. Additionally, in the case of ASXL2,
the ~40 amino acid region upstream of the EH[N/S]Y
motif is well-conserved; in particular, a distinct LE[A/
E]G[E/Q] motif was observed at the beginning of this
region (positions 113–117 in Fig. 5).
We searched the eukaryotic linear motif (ELM) database
[32] using the predicted human TF peptide sequences to
determine whether any of the highly conserved regions
might comprise known functional motifs. This analysis
revealed that the core EH[N/S]Y sequence matches the
metazoan Host Cell Factor-1 (HCF-1) binding motif
(HBM), which has the consensus [D/E]HxY [33, 34]. For
both ASXL1 and ASXL2, this was the most significant
database match for the entire TF peptide sequence
(p = 5.1 × 10−5). The EH[N/S] Y motifs also coincide with
distinct peaks in synonymous site conservation (Fig. 3 and
Additional file 1: Figure S3) indicating that these sites are
subject to particularly strong evolutionary constraints. A
zero-frame amino acid sequence corresponding to +1
frame EH[N/S]Y is necessarily highly constrained – for
example, the first two positions can only be R/G and T/A
respectively; yet all four amino acids were common at
Fig. 5 Amino acid composition of ASXL2 TF peptide sequences. To avoid over-representation of closely related sequences, the sequence logo is
based on an alignment of 52 sequences from phylogenetically diverse taxa (see Additional file 1: Figure S2). Selected representative sequences
are shown beneath the logo. Partial-width logo letters correspond to positions with alignment gaps (i.e. fewer contributing sequences). Note that
teleost fish lack the ASXL2 TF ORF
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these positions, for example human ASXL1 and ASXL2
have zero-frame RTQLL and GAQLQ respectively at this
site, confirming that conservation of +1 frame EH[N/S]Y
is not due to zero-frame coding constraints.
Structural analyses of TF peptides
No significant homology was found between the TF pep-
tide sequences and tertiary structural domains within
the InterProScan [35] or NCBI conserved domains [36]
databases. We used the Predictor of Natural Disordered
Regions (PONDR®) algorithm to infer ordered and dis-
ordered segments in the full-length ASXL1 and ASXL2
proteins of humans (Additional file 1: Figure S5; left
panel, top and bottom, respectively) and in the pre-
dicted frameshift products ASXL1-TF and ASXL2-TF
(Additional file 1: Figure S5; right panel, top and bot-
tom, respectively). The TF regions were inferred to be
largely disordered (Additional file 1: Figure S5; right
panel, highlighted sections). However, it is notable that
the C-terminal EH[N/S]Y motifs are predicted to be
found within locally ordered segments of the trans-
frame products. Combined with the analyses of residue
conservation discussed above, these data suggest that
the TF peptides do not harbour functional tertiary
structures, but they may exert a regulatory impact by
means of conserved short linear motifs.
Analysis of ribosome profiling datasets
Ribosomal frameshifting into the TF ORF would result
in a proportion of translating ribosomes terminating at
the TF stop codon, leading to a step-wise decrease in
ribosome density at this site that might be apparent in
ribosome profiling datasets [5, 37]. Due to variability
in read density as a result of library preparation biases
(nuclease, ligation, reverse transcription, PCR, etc), ribo-
some profiling is unlikely to be sensitive enough to detect
intragenic drop-off at levels of ~20% or less, let alone the
1–2% frameshifting, previously measured by metabolic
labelling, on the UCC_UUU_CGU shift site in the
influenza A virus sequence context. Nonetheless, we
inspected ASXL genes in ribosome profiling datasets on
the GWIPS-viz genome browser [37]. Most datasets did
not show noticeable drop-off at the end of the TF ORF for
either ASXL1 or ASXL2, though a few data sets showed
moderate to strong drop-off. To more clearly visualize
ribosome drop-off, we removed intronic regions by re-
mapping datasets to ASXL1 and ASXL2 mRNA tran-
scripts. Two examples – Jurkat cells from Gawron et al.
[38] and MDA-MB-231 cells from Rubio et al. [39] – are
shown in Additional file 1: Figure S6. For ASXL1, the
mean ribosome footprint density downstream of the TF
ORF was 0.15 times the mean density upstream of the TF
ORF in Jurkat cells, whereas in MDA-MB-231 cells the ra-
tio was 1.01, indicating that 85% of ribosomes drop off the
ASXL1 mRNA within the TF region in Jurkat cells but not
in MDA-MB-231 cells. For ASXL2 the ratios were less ex-
treme and much closer to each other – 0.69 and 0.85 in
Jurkat and MDA-MB-231 cells respectively – making it
harder to distinguish TF-specific drop-off from potential
generic decreases in ribosome footprint density perhaps
due to other causes.
While the Jurkat ASXL1 ribosome drop-off ostensibly
supports efficient PRF in certain cell types, we are suspi-
cious that this particular result is an artefact of heterozy-
gous somatic mutations. Jurkats are a pseudodiploid cell
line, with polyploidy occurring in a moderate percentage
of cells. Analysis of Gawron et al. RiboSeq reads
(typically ~30 nt) mapping to the ASXL1 TF region re-
vealed two indel mutations – a GCCCG to GCCCCG in-
sertion present in 29 of 74 reads and a AGGGGGGGGU
to AGGGGGGGU deletion present in 5 of 5 reads. The
former mimics a −1 frameshift leading to premature ter-
mination in the middle of the TF ORF. The latter mimics
a +1 frameshift leading to termination at the TF stop
codon. Interestingly, to our knowledge Jurkat cells have
not been reported to have indels in ASXL1 (https://cansar.-
icr.ac.uk/cansar/cell-lines/JURKAT/), and analysis of gen-
omic sequencing datasets (SRX2596625, SRX2596624;
150-nt reads) also did not reveal indels at these sites. Thus
the Gavron et al. indels may be specific to their isolate of
the Jurkat cell line. In summary, therefore, current ribo-
some profiling datasets neither support nor contradict the
PRF hypothesis. However, given that the PRF efficiencies
involved may be of order a few percent, it is likely that
ASXL PRF would not be detectable by this approach.
Discussion
Hitherto, most documented cases of PRF have been
found to occur within mobile genetic elements and par-
ticularly in the genomes of RNA viruses [1]. Less atten-
tion has been paid to frameshifting as a gene expression
mechanism in cellular organisms; however, there are a
small number of notable instances of both prokaryotic
and eukaryotic chromosomal genes whose expression is
dependent upon PRF [1]. The efficiency of frameshifting
in two such cases (prokaryotic release factor 2, and
eukaryotic antizyme) is regulated via feedback loops. For
example, the antizyme genes of yeast and metazoa
consist of two partially overlapping reading frames
(ORF1 and ORF2), and +1 PRF at the last codon of the
former is required for the translation of full-length, bio-
chemically active antizyme proteins [40]. Frameshifting
at these sites is responsive to cellular polyamine levels,
which are, in turn, decreased by the actions of the
antizyme proteins; thereby completing an autoregulatory
circuit [11, 41]. The antizyme frameshift site consists
of a highly conserved UCC_UGA sequence, as well
as more divergent flanking sequences, including a
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specific 5′ sequence and a pseudoknot located 3′ of
the shift site [40, 42].
In the case of the putative frameshift sites in the ASXL1
and ASXL2 genes, we found no clear evidence for the ex-
istence of conserved flanking RNA structures, either pseu-
doknots or stem loops (see Methods). It is possible that
more rapidly evolving, lineage-specific structures might
play a role in either or both cases; or that trans-acting fac-
tors might be involved, as has been shown for −1 PRF in
cardioviruses and −2 PRF in arteriviruses [4, 5]. Clearly,
experimental data will be required to determine the pro-
pensity of ribosomes to transition between reading frames
on ASXL mRNAs, and to shed light on the efficiency and
stimulators. However, given that the expression levels of
ASXL genes are tightly controlled across distinct tissues
and cell types [17], it seems plausible that PRF might also
be regulated in these genes.
Frameshifting at the predicted sites is expected to give
rise to the truncated forms, ASXL1-TF and ASXL2-TF.
Since the TF stop codon is located within the last exon,
frameshifting – even if highly efficient – is not expected
to lead to nonsense-mediated decay of ASXL mRNAs
[43, 44]. ASXL1-TF and ASXL2-TF retain the N-proximal
ASXN and BAP1-binding ASXH domains (Fig. 1), but
contain an alternative C-terminal region harbouring a
conserved EHXY motif, homologous to the binding site
for the transcriptional co-regulator HCF-1 [45]. HCF-1 in-
teracts with transcription factors [34, 46] and with chro-
matin modulation complexes [47] via its N-terminal kelch
repeat beta propeller domain, to control cell proliferation
and the expression of homeotic genes [48, 49], in a cell
cycle dependent manner [50–52]. Interestingly, although
no direct link has been found between HCF-1 and full-
length ASXL1 or ASXL2, full-length ASXL1, ASXL2 and
HCF-1 have been shown, independently, to be amongst
the strongest binding partners of the BAP1 deubiquitinase
[50–56]. ASXL proteins interact with BAP1 to form the
polycomb repressive deubiquitinase (PR-DUB) complex,
which removes monoubiquitin from histone 2A at lysine
119 (H2AK119) [21, 23]. Our data now raise the intriguing
possibility that the frameshifted isoforms ASXL1-TF and
ASXL2-TF might compete with BAP1 for binding to
HCF-1 and thus provide an alternative link between BAP1
and HCF-1 in a reconfigured complex that also lacks the
ASXL C-proximal histone-interacting PHD domain.
Nonsense and frameshift-inducing mutations giving rise
to truncated isoforms of ASXL1 are among the most
frequently observed mutations in myeloid malignancies
[24, 57]. Such mutations are usually heterozygous
suggesting a gain-of-function or dominant negative effect
[44, 58, 59] although loss-of-function has also been pro-
posed [60–62]. Similarly, heterozygous germline truncation
of ASXL1 is the underlying cause of Bohring-Opitz syn-
drome [63], and related but distinct neurodevelopmental
anomalies are associated with heterozygous germline trun-
cation of ASXL2 [44]. As the mutant isoforms typically
contain the ASXH domain (Fig. 1), they retain the ability
to associate with BAP1 [58]. The resulting protein com-
plexes exhibit enhanced H2AK119 deubiquitinating
activity, leading to secondary loss of histone H3 lysine 27
trimethylation (H3K27me3) marks and the widespread ac-
tivation of genomic loci which are otherwise epigenetically
silenced [58]. The mutant isoforms typically have a domain
structure similar to ASXL-TF except that they generally
(but not always) lack the C-terminal EH[N/S]Y motif. Fur-
ther, the mutant forms will presumably be translated at the
normal level of ASXL (though the resulting mutant pro-
teins may be unstable) whereas ASXL-TF should be less ef-
ficiently expressed and/or regulated. Thus we predict that
disease-associated ASXL truncation mutants represent de-
fective overexpressed versions of a natural functionally im-
portant ribosomal frameshifting product ASXL-TF.
Conclusions
In this study, we have demonstrated the existence of con-
served overlapping ORFs in the +1 frames of the verte-
brate ASXL1 and ASXL2 genes. These “TF ORFs” coincide
with highly significant synonymous site conservation in
the corresponding zero-frame sequences, as is typically
observed for dual coding regions, where selective con-
straints operate on more than one reading frame [28]. The
TF ORFs are not canonically translatable within any
known splice variants of the human ASXL genes. How-
ever, the presence of highly conserved motifs at the 5′
ends of the TF ORFs, identical to known +1/−2 PRF shift
sites, suggests that the TF peptides may be expressed as
transframe fusions with zero-frame ASXL via ribosomal
frameshifting. The third paralogue, ASXL3, is more diver-
gent and has neither a conserved long overlapping +1
frame ORF nor a conserved +1-frame EHxY motif.
Methods
The initial set of 37,257 human mRNA RefSeqs was
downloaded from NCBI in January 2010.
To identify further orthologues of ASXL1 and ASXL2,
tblastn searches of the nr/nt NCBI database were carried
out, using selected reference species for each major ver-
tebrate clade. For clades with poor representation in the
nr/nt database, sequences from the transcriptome shot-
gun assembly (TSA) database were added, where avail-
able. To avoid the detection of non-orthologous genes, a
minimum query coverage threshold of 80% was used to
filter all results. Nucleotide sequences for each gene
were retrieved from NCBI. RefSeq entries with missing
or incomplete sequence data that precluded further ana-
lyses were discarded. Where multiple transcript isoforms
were present for a given species, the lowest numbered
isoform was used for analyses.
Dinan et al. Biology Direct  (2017) 12:24 Page 9 of 16
The ASXL2 gene predictions of many sauropsids
(reptiles and birds) have large (~150 aa) N-terminal
deletions relative to those of all other major vertebrate
clades. Because we set a minimum query coverage
threshold of 80%, these genes were excluded from our
analyses. However, examination of the relevant genomic
and transcriptomic sequences shows that all contain
conserved copies of the frameshift site – with the excep-
tion of lizards, as discussed above – and large TF ORFs
in the expected frames.
For each of ASXL1 and ASXL2, full-length zero-frame
coding nucleotide sequences were translated, aligned as
amino acids with MUSCLE [64], and the amino acid
alignments were used to guide codon-based nucleotide
alignments using EMBOSS tranalign [65]. The zero-
frame sequences of all mRNAs were scanned for the
relevant +1 or −2 PRF sites. Sequence alignments were
analysed for synonymous site conservation using syn-
plot2 [28] with amino acid PhyML guide trees [66]; for
these analyses, alignments were mapped to reference se-
quence coordinates by removing alignment columns that
contained a gap character in the reference sequence
(mammalian/tetrapod, sauropsid, amphibian and teleost
reference sequences respectively ASXL1: NM_015338 –
Homo sapiens, XM_015296597 – Gallus gallus, XM_
012952772 – Xenopus tropicalis, XM_005162338 –
Danio rerio, and ASXL2: NM_018263 – Homo sapiens,
NM_001031096 – Gallus gallus, XM_018089999 –
Xenopus tropicalis).
For sequence logos, we selected subsets of sequences
(76 for ASXL1 and 52 for ASXL2; see Additional file 1)
that more uniformly covered the sampled vertebrate
phylogeny, to enable a representative assessment of nu-
cleotide and amino acid composition. Sequence logos
for visualization of amino acid conservation within the
TF peptides, and nucleotide conservation at the putative
frameshift sites, were created using WebLogo [31]. The
Predictor of Natural Disordered Regions (PONDR®) [67]
was used to predict disordered regions within the ASXL
and ASXL-TF proteins, using the VL-XT algorithm.
To search for potentially stable RNA structures adja-
cent to putative frameshift sites, we extracted the 120-nt
regions downstream of all putative shift sites and aligned
them using Clustal Omega [68]. Consensus structures
from those alignments were predicted using RNAalifold
[69]. We also scanned each individual sequence for po-
tential pseudoknots using PKNOTS [70].
RiboSeq datasets were retrieved from the NCBI short
reads archive (accessions SRR2733100, SRR1573934 and
SRR1573935 for Jurkat RiboSeq, MDA-MB-231 RiboSeq
and MDA-MB-231 RNASeq, respectively) and mapped
to human rRNA, then to the ASXL1 and ASXL2 trans-
cipts (NM_015338.5 and NM_018263.4 respectively).
Reads were mapped using bowtie version 1 [71], with
parameters -v 2 --best (i.e. maximum 2 mismatches, re-
port best match). Ribosome footprint densities were cal-
culated for the regions upstream and downstream of the
TF ORF, excluding five codons proximal to the start and
stop codons and the frameshift site. Footprints were
counted as mapping to this region if the 5′ end
coordinate with a +12 nt offset (the approximate ribo-
some P-site position) mapped within this region.
To identify ASXL1 TF-region indels in the Gawron et
al. Jurkat RiboSeq dataset, all 15-mers from 330 nt up-
stream of the TF ORF to 74 nt downstream of the TF
ORF were queried against all post-rRNA subtraction se-
quencing reads. The resulting reads were inspected by
blast [72] (blastn to ASXL1 mRNA, selection of align-
ments with >0 gaps) and velvet [73] (de novo assembly
with velvet and blastn of contigs to ASXL1 mRNA).
Once the two indels had been identified, the wildtype
and mutant sequences at each site were used to extract
and count the number of raw reads containing the
wildtype or mutant sequences. Genomic DNA sequen-
cing of Jurkat cell NCBI short read archive datasets
SRX2596625 and SRX2596624 were queried using NCBI
blastn with parameters, algorithm = blastn, max target
sequences = 500, word size = 15, no low complexity fil-
tering, and query = NM_015338.5 nt 2228–2426 (i.e. the
region between the two indels plus 60 nt on either side),
either wildtype sequence or the sequence with the two
indel mutations, and the results inspected for presence/
absence of indels.
Reviewers’ comments
Reviewer’s report 1: Eugene Koonin, NCBI, NLM, NIH, USA
The manuscript by Dinan et al. reports a previously un-
noticed programmed frameshift in ASXL, an important
human gene, and make inferences regarding the func-
tionality of the frameshift proteins and the effects of its
disruption by mutation. The analysis is done very care-
fully and discussed thoroughly, so I have no substantial
criticisms. My only concern is that the manuscript is far
too long for a Discovery Note. I think it has to be a
regular research article, which will involve some restruc-
turing, particularly, in the Abstract.
Authors’ response: We thank Professor Koonin for his
positive assessment of the manuscript. We have now
restructured the manuscript as a regular research article.
Reviewer’s report 2: Laurence Hurst, University of Bath,
UK
Summary: An interesting possible example of pro-
grammed frame shifting in vertebrates. The evidence is
consistent but a lack of direct evidence of the short form
of the protein and of its functionality render the case
only partially made. Possible alternative interpretations
of the data cannot yet be fully discounted.
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Authors’ response: We agree that other possible
explanations cannot be completely discounted pending
experimental work. However we were cautious in our as-
sessment of the evidence and avoided making definitive
statements about frameshifting, instead opting for terms
such as “hypothesis”, “putative”, “most plausible”, etc. We
also carefully considered possible alternative explana-
tions in the paragraph beginning “We considered possible
explanations for TF ORF expression, other than riboso-
mal frameshifting”.
After an initial trawl for vertebrate sequences contain-
ing a conserved motif associated with programmed fra-
meshifting in viruses, the authors identify a gene that
looks like it might use this mechanism (ASXL1). A fur-
ther member of the gene family (ASXL2) might similarly
use programmed frameshifting but employing a different
motif. We can question whether there are alternative in-
terpretations of the data as presented and what other
evidence would both make a more convincing case that
the frameshifted protein is made and if made, functional.
Evidence for the programmed frameshift presented by
the authors is suggestive but not definitive.
Authors’ response: Only experimental verification will
provide definitive evidence. This will be difficult if the
frameshifting efficiency is of order 1–2%, as predicted
from the nature of the shift site. Given that the bioinfor-
matic observation has great relevance to understanding
the disease phenotype of ASXL truncation mutants, we
feel that there is merit in timely publication of the bio-
informatic observations.
It is hard to know what to make of the evidence that
one other member of the family has a different motif as-
sociated with frameshifts – could this be an ascertain-
ment bias? How often would you find such motifs if you
looked at a random gene?
Authors’ response: From a set of 9736 human-
chimpanzee-cow-mouse-chicken orthologues we found 25
genes with a G_GUC_UCU sequence conserved between
human and chicken (MUSCLE amino acid alignment,
back-translated to codon alignment). Only eight of these
were also conserved in cow, chimpanzee and mouse. One
of these is ASXL2.
It is true that there are other potential −2 frameshift
motifs, although all known ones in vertebrate systems (i.e.
those identified in arterivirus species) contain UU_UUU,
UC_UCU or UU_UUC for codon:anticodon re-pairing in
the A-site following a −2 frameshift [1]. As can be seen
from Fig. 2b, the G_GUC_UCU stands out alone as being
completely conserved while adjacent codon positions show
variation. One may say that of 61 × 61 possible non-stop
codons at these two adjacent sites, only 12 in 3721 combi-
nations (i.e. NUC_UCU, NUU_UUU, NUU_UUC) would
give one of the known viable A-site −2 slippage pentanu-
cleotides, while only 4 in 3721 (i.e. UUU_CGN) would give
rise to the UUU_CG that is the core of the only known
mammalian +1 frameshift pattern that does not require a
stop codon in the zero-frame A-site as in the antizyme
genes [6].
While it looks like a coincidence too strong to be dis-
missed as an accident, it is curious that the usual RNA
structures associated with frameshifts aren’t seen (but
these can be quite far away [1]).
Authors’ response: On the contrary, like many +1 frame-
shift sites, the influenza virus UCC_UUU_CGU +1 frame-
shift site apparently has no stimulatory RNA secondary
structure [1, 7]. Similarly, the only confirmed case of −2
frameshifting on a G_GUC_UCU sequence (i.e. in arteri-
viruses) has no stimulatory RNA secondary structure [1, 4].
The strongest evidence that there is a functional fra-
meshifted protein produced is all indirect: the conserva-
tion of synonymous sites in the zero (normal) reading
frame and a conserved protein-level motif in the frame-
shifted sequence. In addition, the frameshifting 5′ motif
is also conserved.
Authors’ response: And also the conserved presence of
a lengthy overlapping ORF across the entire vertebrate
lineage in ASXL1, and across vertebrates except teleost
fish in ASXL2.
Conservation of the frameshift initiation motifs in
ASXL1 is supportive, but this is also how this site was
identified so is not independent evidence.
Authors’ response: The site was identified due to its
conservation in just human, mouse, chimpanzee, cow
and chicken, but was then found to be conserved in 200
species spanning mammals, birds, reptiles, amphibians,
teleost fish, shark, gar, and coelacanth.
Moreover with motifs this small other explanations
could be considered, such as miRNA pairing sites [74],
transcriptional enhancers or RNA binding protein motifs
in the zero frame [75–78].
Authors’ response: The conserved presence of the
lengthy overlapping TF ORF across the entire vertebrate
lineage argues for a translational explanation. Given the
absence of suitable AUG initiators in the TF ORF, and
the presense of a conserved ribosomal frameshift site cor-
responding precisely to the 5′-most peak in synonymous
site conservation (Additional file 1: Figure S3), the sim-
plest explanation is ribosomal frameshifting. We agree
that, pending experimental verification, other possibilities
cannot be ruled out.
Likewise, can we be confident that the putative con-
served C terminal motif in the non-zero frame is not
similarly constrained in the zero frame that would result
in off frame apparent protein conservation?
Authors’ response: This was discussed in the manu-
script – see the text: “The EH[N/S]Y motifs also coincide
with distinct peaks in synonymous site conservation
(Fig. 3 and Additional file 1: Figure S3) indicating that
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these sites are subject to particularly strong evolutionary
constraints. A zero-frame amino acid sequence corre-
sponding to +1 frame EH[N/S]Y is necessarily highly con-
strained – for example, the first two positions can only
be R/G and T/A respectively; yet all four amino acids
were common at these positions, for example human
ASXL1 and ASXL2 have zero-frame RTQLL and GAQLQ
respectively at this site, confirming that conservation
of +1 frame EH[N/S]Y is not due to zero-frame coding
constraints.”
The interpretation of the conservation of synonymous
sites in the zero frame is yet more complex as the ex-
pected TF protein end is computationally predicted to
be disordered (sort of what you might expect if this was
not a programmed frameshift but instead just part of the
rubbish that cells produce all the time or a computa-
tional artefact).
Authors’response: On the contrary, overprinted genes
often tend to have relatively large amounts of predicted
disorder [79]. It seems that the dual coding constraints
imposed by overlapping genes makes them more amen-
able to evolving within disordered regions, or to them-
selves contain disordered regions.
If it is disordered, why need there be selection on the
frameshift protein to impact zero frame synonymous
sites, as disordered domains tend to be under much
weaker purifying selection [80]?
Authors’ response: “Disorder” is not the same as “com-
pletely random”. Even disordered regions of proteins can
be subject to purifying selection, and disordered regions
contain locally ordered regions and/or other functionally
important sequences. Note in particular that the con-
served HCF-1 binding motif in TF corresponds precisely
to one of the peaks in synonymous site conservation
within the overlapping ORF region (Additional file 1:
Figure S3).
Further, a closer look at synonymous site conservation
in ASXL2 suggests a section of the overlap might have
lower (not higher) than than expected synonymous site
conservation (Fig. 3a and b, right panel). Indeed, in both
genes synonymous site conservation appears to be weak-
ened at the central overlap section. This would fit either
with the authors’ model and reduced constraint on dis-
ordered proteins, or with the possibility that there is se-
lection on the zero phase at DNA or RNA level at a few
intragene locations one of which happens to include a
putative frameshifting motif (which may or may not
initiate frameshifting).
Authors’ response: Despite the lack of purifying selec-
tion on the middle region of the TF ORF (which could be
due to it being a linker region) there is still a conserved
absence of +1 frame stop codons in this region.
The authors argue against the presence of an out of
frame alternative splice form and against a different
initiation site. Elimination of alternative splice forms as
an explanation requires much deep sequencing and in
the end would rely on evidence of absence. Transcripto-
mics is pretty deep in humans so absence of evidence is
pretty good evidence.
Regarding, the alternative initiation site, they presume
that transcripts must start with ATG, but nonATG
initiation is known [81]. Can this be ruled out? Indeed,
nonATG starts are associated with viral expression [3]
(HERVH-associated [82] ESRG for example uses a non-
canonical start codon [83]).
Authors’ response: We are very familiar with references
[81] and [3] and certainly did not forget the possibility of
non-AUG initiation. However a long-winded discussion of
presence or absence, and conservation and context of every
“standard” non-AUG initiator (i.e. CUG, GUG, UUG,
ACG, AUA, AUU, AUC), besides the possibility of non-
standard non-AUG initiators in the context of dicistrovirus-
like IRESes [84], would not add clarity to the manuscript.
In the absence of evidence for a suitable transcript where
such a codon would be accessible via 5′-end-dependent
scanning, independent initiation in the TF frame is unlikely.
The note on lack of suitable AUG initiators only serves to
reinforce this. Of note, the highly conserved frameshift sites
which correspond closely to the 5′-most peak in synonym-
ous site conservation (Additional file 1: Figure S3) do not
contain any of the standard non-AUG initiators.
I note too that nonATG starts can be associated with
CAG repeats [85] one of which (CAG)4 occurs at
position 76,695 in the genomic sequence (in exon 9).
Whether this is anything other than a spurious finding is
hard to say, but I don’t think unusual initiation can be
so easily dismissed.
Authors’ response: Being in exon 9, the (CAG)4site in
question is not relevant since there are many intervening
stop codons between here and the TF ORF. Any +1 frame
initiation here would not allow access to the TF ORF.
Also, on the canonical ASXL1 transcript, there are no
fewer than 13 AUG codons (in human) between the
ASXL1 initiation AUG and the (CAG)4, thus it is hard to
imagine how pre-initiation scanning ribosomes could
come anywhere near the (CAG)4sequence.
If the authors consider it possible that the sequences
might make use of one viral trick – frameshifting – why
could an alternative viral trick not be an equally good
(or at least alternative) explanation?
Authors’ response: As explained above, potential non-
AUG initiation would require an independent transcript,
likely with no +0 or +2 frame AUGs upstream of a
potential +1 frame non-AUG initiator, and in addition
one would need to propose that the conserved shift sites
serve some other unknown purpose.
Evidence from deep transcriptomics to exclude a tran-
script running across the putative frameshift but not much
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further 5′ would strengthen the case for a programmed
frameshift rather than alternative initiation site.
Authors’ response: Unfortunately if one starts to look
for very rare transcripts in the public databases one will
(i) not be able to conclude whether they are complete
transcripts or just fragments, and (ii) enter the realm of
transcriptional noise and experimental artifact. E.g. a
common mutation in ASXL1 is an insertion of an add-
itional G in a GGGGGGGG sequence near the 3′ end of
the TF region (a deletion at this site would allow access
to the C-terminus of TF). However, ref. [86] comment
that a substantial fraction of the published mutants at
this site are actually due to sequencing errors presumably
as a result of the homopolymeric run.
In this context, I notice that if you do a BLASTP of
the ASXL1 TF sequence (just the TF portion) you pick
up the C terminal section of a rather short predicted
protein in naked mole rats (EHB11723). This starts at
position 282 in the 360 amino acid mole rat sequence,
making this protein about half the length of the human
putative ASXL1-TF and suggestive of the possibility of
an alternative start codon.
Authors’ response: This analysis was already discussed
in the manuscript. We carried out searches via BLASTP
of the NCBI non-redundant database using the human
ASXL TF amino acid sequences as queries. Very few
matches were found – just three hits for each of ASXL1
and ASXL2 TF, using default search parameters. In every
case, the sequence of the hit was predicted computation-
ally from the genomic sequence of that organism, and
each of the associated genomic sequences contains large
gap regions that likely confounded the automated gene
annotation. These six predicted protein sequences are
ASXL1 – aa EHH65433.1, Macaca fascicularis, DNA
CM001285.1; aa EHB11723.1, Heterocephalus glaber,
DNA JH171429.1 (naked mole rat); and aa EPY85029.1,
Camelus ferus, DNA KB016696.1; ASXL2 – aa
XP_013150379.1, Falco peregrinus, DNA NW_00492
9857.1; aa XP_009330622.1, Pygoscelis adeliae, DNA
NW_008825559.1; and aa OBS64385.1, Neotoma lepida,
DNA LZPO01097212.1.
In the naked mole rat hypothetical protein sequence,
EHB11723, the annotation starts in the zero-frame close
to the canonical ASXL1 initiation site and enters the C-
terminal half of TF via a predicted splice. So this has
nothing to do with “an alternative start codon” and also
doesn’t explain the synonymous site conservation and
conserved absence of stop codons in the 5′ half of the
TF region.
Sequencing databases are now so large that for many
analyses one will pick up a number of aberrant sequences
in isolated taxa, but these cannot be taken as evidence
for an alternative mechanism unless the same features
are conserved among multiple species.
However, I see nothing in ENSEMBL that suggests an
abbreviated transcript in human ASXL1, but for ASXL2
they annotate a transcript with an earlier initiation site
with 10 rather than 13 exons and a smaller protein
(ENST00000404843.5). It would be good if the authors
can provide a more uptodate analysis of the various anno-
tated forms and how they relate to the various hypotheses.
Authors’ response: The ORF in this transcript misses
the first 260 codons of the main ORF in NM_018263
(human ASXL2 NCBI RefSeq) and also 259 codons from
the last exon of the RefSeq due to an additional splicing
event. It does not however provide non-frameshifting ac-
cess to the TF ORF. This transcript form appears to be
based on the single cDNA clone BC042999 and the splice
junction is not supported by EST or TSA databases, so it
may be aberrant. Since it is not relevant to TF ORF ex-
pression we chose not to mention it in the manuscript.
We retrieved all currently annotated splice forms for
Homo sapiens from the most recent release of the NCBI
RefSeq database (ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/
vertebrate_mammalian/Homo_sapiens/latest_assembly_
versions/GCF_000001405.37_GRCh38.p11/; July 2017 ). In
total, there are six isoforms annotated for each protein.
These isoforms encode proteins with lengths ranging from
1313 aa to 1628 aa for ASXL1, and from 1175 aa to 1435
aa for ASXL2, owing largely to several distinct initiation
sites being annotated. Crucially, in both cases, variation in
amino acid sequence is restricted exclusively to N-terminal
regions, far from the TF region. For ASXL1, all sequences
are identical from ~300 aa upstream of the putative
frameshift site until the end of the protein; while for
ASXL2, all sequences are identical from ~370 aa upstream
of the putative frameshift site until the end of the protein.
To some degree all these issues would be irrelevant
were there direct evidence for the truncated form of the
protein and for its functionality. More generally then,
the most obvious omission in the analysis is the lack of
more direct evidence that the truncated proteins, as pre-
dicted by the frameshifting hypothesis, are produced and
functional. The Riboseq data is cautiously interpreted by
the authors (to their credit) and doesn’t appear decisive.
I agree to that if the frameshift is seen only 1–2% of the
time, as in viruses, that Riboseq may well not be refined
enough to detect this. Is there no mass spec data to sup-
port the presence of the short form protein?
Authors’ response: Again, the likely 1–2% level of frame-
shifting would make it very difficult if not impossible to de-
tect TF peptides in publicly available whole-proteome
mass spectrometry databases. To find previously unknown
peptides – such as from TF – also requires access to raw
mass spectra. Even where these are available, we do not
have access to corresponding DNA sequencing to rule out
possible somatic mutations (cf. the section in the manu-
script on public ribosome profiling data).
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Even if the frameshift occurs, it could be caught by
NMD, the rules for which remain poorly understood [87].
The authors note that as the stop of the frameshift is in the
terminal exon in both genes NMD is not expected detect
the new stop of the highly abbreviated CDS under normal
understanding of NMD [87]. However, the 10 exon form
noted above appears to split the last exon into two small
exons, meaning a frameshift stop could have the potential
to be in the last but one exon and hence caught by NMD.
Authors’ response: The canonical splice form would
still be expected to be resistant to NMD even if this pos-
sible alternative transcript form is not.
It would then be good to see that knockdown of NMD
doesn’t lead to upregulation of transcripts of the two
genes, but, again, with a low frameshifting rate this may
be too subtle to detect. Assuming the protein is made it
would be good to have direct evidence for the putative
novel interactions from protein interaction data. Indeed,
a lovely experiment would be to use HCF-1 as a bait and
see if you can extract the TF proteins.
Authors’ response: Indeed this potential experiment
had not escaped our notice.
To date BioGrid doesn’t mention any such interaction,
although it does mention a weak interaction with both
ASXL1 and ASXL2.
Authors’ response: The fact that ASXL-TF is not, at
the time of review, in the public domain provides an easy
explanation as to why its interactions are not mentioned
in BioGrid.
In conclusion the frameshift model is a parsimonious
model to explain the observations, but cannot be consid-
ered as more than an hypothesis at present.
Authors’ response: We agree, and that is the light in
which we have presented it.
Additional file
Additional file 1: Supplementary figures and supplementary files.
(PDF 2721 kb)
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